Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B. Halpern, Roland B. Walter, Mary‐Elizabeth M. Percival et al.|Leukemia|2026Cited by 0